WASHINGTON - Evolent Health, Inc. (NYSE:EVH) has announced the appointment of Russell Glass, current CEO of Headspace, to its Board of Directors. Glass, an experienced executive with a background in technology and health care, will fill the seat left by Dr. Tunde Sotunde, who retired on February 12, 2024.
Russell Glass brings nearly a quarter-century of industry experience to the Evolent board, having held various leadership roles, including CEO of Ginger, a mental health platform, before its merger with Headspace in 2022. His career also includes tenure as CEO and President of Bizo, a business-to-business marketing and data platform, which was acquired by LinkedIn in 2014.
Evolent's CEO and Co-founder, Seth Blackley, expressed gratitude to Dr. Sotunde for his contributions and welcomed Glass, highlighting his valuable expertise at a critical juncture for the company. Glass, in turn, remarked on the shared goals between Headspace and Evolent in addressing health care challenges, such as patient experience and affordability.
Cheryl Scott, Chair of the Evolent Board, emphasized the Board's satisfaction in appointing Glass after a comprehensive search, noting his deep understanding of health care technology and the intersection of complex care and mental health. She also pointed out that Glass's appointment complements the existing Board's health care and financial acumen.
Evolent Health focuses on delivering better health outcomes for individuals with complex conditions, pairing simplicity and affordability. The company is recognized as a leader in the value-based specialty care market and has been acknowledged as a top workplace in the health care sector.
This board appointment, based on a press release statement, marks a strategic enhancement to Evolent Health’s leadership as the company continues to navigate the evolving landscape of health care services and technology.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.